FILE - In a Saturday, Aug. 13, 2016 file photo, logo of Swiss pharmaceutical company Novartis is seen at the Novartis Korea office in Seoul, South Korea. U.S. regulators have approved a new drug as an initial treatment for postmenopausal women with a type of advanced breast cancer. The drug, called Kisqali, developed by Swiss drugmaker Novartis, is a pill that works to slow the spread of cancer by blocking two proteins that can stimulate growth and division of cancer cells. (AP Photo/Ahn Young-joon, File)
Featured Photo Galleries
